Filing Details
- Accession Number:
- 0001209191-22-059532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-02 21:00:15
- Reporting Period:
- 2022-12-02
- Accepted Time:
- 2022-12-02 21:00:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1630627 | Treace Medical Concepts Inc. | TMCI | Surgical & Medical Instruments & Apparatus (3841) | 471052611 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1858105 | E. Daniel Owens | C/O Treace Medical Concepts, Inc. 100 Palmetto Park Place Ponte Vedra FL 32081 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-02 | 3,750 | $7.03 | 14,450 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-02 | 3,750 | $25.00 | 10,700 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-12-02 | 1,875 | $17.00 | 12,575 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-02 | 1,875 | $25.00 | 10,700 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option Right to Buy | Disposition | 2022-12-02 | 3,750 | $0.00 | 3,750 | $7.03 |
Common Stock | Stock Option Right to Buy | Disposition | 2022-12-02 | 1,875 | $0.00 | 1,875 | $17.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
182,625 | 2031-02-02 | No | 4 | M | Direct | |
71,688 | 2031-04-22 | No | 4 | M | Direct |
Footnotes
- The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Includes 6,700 RSUs.
- The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
- The stock option vests in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.